Class 2 Drug Alert (Action within 48 hours): Boehringer Ingelheim Ltd - Oramorph Oral Solution 10mg/5ml

---

Dear Healthcare Professional,

Batch Number	Expiry Date	Pack Size	First Distributed
833206A	30/09/2011	100ml	16/10/2008
833207A	30/09/2011	100ml	27/10/2008
833208A	30/09/2011	100ml	05/11/2008
833209A	30/09/2011	100ml	13/11/2008
832873B	31/08/2011	300ml	23/09/2008
833210A	30/09/2011	300ml	20/10/2008
833214A	30/09/2011	500ml	21/10/2008
833215A	30/09/2011	500ml	07/10/2008
833216A	30/09/2011	500ml	28/10/2008
833217A	30/09/2011	500ml	11/11/2008

Boehringer Ingelheim Ltd are recalling all remaining stock of the above batches due to several complaints regarding deviation in taste and some non-serious adverse events.

We understand that this product is used in hospitals and is also supplied via community pharmacies.

All unused stock of the above batches should be quarantined and returned for credit via the original supplier. For returns and credit enquiries, please contact Boehringer Ingelheim Ltd. on 01344 741191.

Medical information can be obtained from the Medical Information Department, Boehringer Ingelheim Ltd via their switchboard, 01344 424600.

Recipients of this Drug Alert should bring this to the attention of relevant contacts by copy of this letter. Primary Care Trusts are asked to bring this information to the attention of relevant clinics, Community Pharmacists and General Practitioners by copy of this letter.

Yours faithfully

Ian Holloway
MHRA DMRC Manager

MHRA Distribution (further recipients by cascade): Regional Contacts for NHS Trusts and Provider Units
Chief Pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief Pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special Hospitals
Healthcare Commission for distribution to Independent Health Care Establishments
Primary Care Trusts (England)